Yearly Archives: 2023

/2023

2023/24 Community Pharmacy Assurance Framework (CPAF) screening questionnaire has opened

The 2023/24 Community Pharmacy Assurance Framework (CPAF) screening questionnaire is now available for completion until midnight on Sunday 30th July 2023. The short screening questionnaire consists of 10 questions. Pharmacy owners who use the NHS Business Services Authority (NHSBSA) Manage Your Service (MYS) portal will be required to complete the questionnaire on the portal. Those who are [...]

The post 2023/24 Community Pharmacy Assurance Framework (CPAF) screening questionnaire has opened appeared first on Community Pharmacy England.

By |July 4th, 2023|Lexpos News|Comments Off on 2023/24 Community Pharmacy Assurance Framework (CPAF) screening questionnaire has opened

Our CEO updates on the negotiations

Pharmacy press Understandably the sector is eagerly awaiting an update on the progress of the negotiations. As many in the sector will know, Community Pharmacy England is bound by government confidentiality protocols. Our CEO has released a statement today to explain that the process remains on track as we’re presently working at pace with key [...]

The post Our CEO updates on the negotiations appeared first on Community Pharmacy England.

By |July 3rd, 2023|Lexpos News|Comments Off on Our CEO updates on the negotiations

GLP-1 receptor agonists shortage

Pharmacy press The Department of Health and Social Care (DHSC) issued a medicine supply notification for GLP-1 receptor agonists used in the management of type 2 diabetes. We were asked to comment on the shortage and how community pharmacists will be dealing with people presenting prescriptions for these products. Director of Pharmacy Funding, Mike Dent, [...]

The post GLP-1 receptor agonists shortage appeared first on Community Pharmacy England.

By |July 3rd, 2023|Lexpos News|Comments Off on GLP-1 receptor agonists shortage

Class 3 Medicines Recall: Sildenafil 100mg Film-coated Tablets (Strandhaven Limited T/A Somex Pharma)

Drug alert number: EL(23)A/21 Date issued: 3 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Sildenafil 100mg Film-coated Tablets (Strandhaven Limited T/A Somex Pharma) – PL 15764/0043 SNOMED Code: 326715008 Batch No Expiry Date Pack Size First Distributed ET22028 02/2025 4 tablets* 16.01.2023 *Mislabelled packs [...]

The post Class 3 Medicines Recall: Sildenafil 100mg Film-coated Tablets (Strandhaven Limited T/A Somex Pharma) appeared first on Community Pharmacy England.

By |July 3rd, 2023|Lexpos News|Comments Off on Class 3 Medicines Recall: Sildenafil 100mg Film-coated Tablets (Strandhaven Limited T/A Somex Pharma)

June 2023 Price Concessions Final Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners (our members), the Department has today (30/06/2023) announced the following list of final price concessions for June 2023: Drug Pack size Price concession * Alginate raft-forming oral suspension sugar free 500 £3.80 Amiloride [...]

The post June 2023 Price Concessions Final Update appeared first on Community Pharmacy England.

By |June 30th, 2023|Lexpos News|Comments Off on June 2023 Price Concessions Final Update